Department of Biology, Lakehead University, Thunder Bay, Canada.
College of Life Science, Shanxi University, Taiyuan, China.
Hydrogen sulfide (H2S) is a novel gasotransmitter that regulates cell proliferation and other cellular functions. Sulforaphane (SFN) is a sulfur-containing compound that exhibits anticancer properties, and young sprouts of broccoli are particularly rich in SFN. There is consistent epidemiological evidence that the consumption of sulfur-containing vegetables, such as garlic and cruciferous vegetables, may help reduce the occurrence of prostate cancer. Here we found that a large amount of H2S is released when SFN is added into cell culture medium or mixed with mouse liver homogenates, respectively. Both SFN and NaHS (a H2S donor) decreased the viability of PC-3 cells (a human prostate cancer cell line) in a dose-dependent manner, and supplement of methemoglobin or oxidized glutathione (two H2S scavengers) reversed SFN-reduced cell viability. We further found both cystathionine gamma-lyase (CSE) and cystathionine beta-synthase are expressed in PC-3 cells and mouse prostate tissues. H2S production in prostate tissues from CSE knockout mice was only 20% of that from wild-type mice, suggesting CSE is a major H2S-producing enzyme in prostate. CSE overexpression enhanced H2S production and inhibited cell viability in PC-3 cells. In addition, both SFN and NaHS activated p38 mitogen-activated protein kinases (MAPK) and c-Jun N-terminal kinase (JNK). Pre-treatment of PC-3 cells with methemoglobin decreased SFN-stimulated MAPK activities. Suppression of both p38 MAPK and JNK reversed H2S- or SFN-reduced viability of PC-3 cells. Our results demonstrated that H2S mediates the inhibitory effect of SFN on the proliferation of PC-3 cells, which suggests that H2S-releasing diet or drug might be beneficial in the treatment of prostate cancer.
Written by:
Pei Y, Wu B, Cao Q, Wu L, Yang G. Are you the author?
Reference: Toxicol Appl Pharmacol. 2011 Oct 8. Epub ahead of print.
doi: 10.1016/j.taap.2011.09.026
PubMed Abstract
PMID: 22005276
UroToday.com Investigational Urology Section
